PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v8i2.6405ArticleThe Application Value of Ultrasound Imaging in the Differential Diagnosis of Benign and Malignant Breast Nodules of BI-RADS 3 and Abovehttps://artdesignp.com/journal/PAR/8/2/10.26689/par.v8i2.6405ChenDongmei2024822024-03-28Objective: To explore the diagnostic value of ultrasound imaging for breast nodules of breast imaging-reporting and data system (BI-RADS) category 3 and above. Methods: From June 2021 to July 2022, 163 patients with breast nodules of BI-RADS 3 or above were selected as the research subjects. After pathological diagnosis, 24 cases were malignant breast nodules of BI-RADS 3 or above, while 139 cases were benign breast nodules of BI-RADS 3 or above. The diagnosis rate of malignant and benign breast nodules of BI-RADS 3 or above, including 95% CI, was observed and analyzed. Results: The malignant and benign detection rates of conventional ultrasound were 88.63% and 75.00%, respectively, and the malignant and benign detection rates of ultrasound imaging were 93.18% and 87.50%, respectively, with 95% CIs greater than 0.7. Conclusion: Ultrasound imaging can help improve the diagnostic accuracy of benign and malignant breast nodules of BI-RADS 3 and above and reduce the misdiagnosis rate.

Shi L, Zhong L, Ma F, et al., 2023, The Value of Peritumoral Ultrasound Imaging in the Differential Diagnosis of Benign and Malignant Breast Nodules. Oncology Imaging, 32(6): 485–491.

Du Y, Feng X, Wu M, et al., 2023, Constructing a Joint Model Based on Ultrasound Imaging to Predict the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Chinese Journal of Ultrasound in Medicine, 39(12): 1353–1356.

Su L, Zhou M, Li Y, et al., 2023, The Application Value of Ultrasound Imaging in the Differential Diagnosis of Benign and Malignant Breast Nodules of BI-RADS 3 and Above. Journal of Bengbu Medical College, 48(8): 1101–1104.

Guo S, 2023, Research on Multi-Regional Elastography and Radiomics Diagnosis of Breast Cancer Based on Ultrasound Images, thesis, Nanchang University.

Qi X, 2023, Research on Breast Cancer Lymph Node Metastasis Prediction Based on Multi-Parameter MRI Imaging, thesis, Shanxi Medical University.

Wang Z, 2023, Research on the Clinical Value of FFDM-Based Radiomics Model in Identifying Benign and Malignant BI-RADS 4 Lesions, thesis, Shanxi Medical University.

Wang H, 2023, Research on the Diagnosis and Metastasis of Breast Cancer and Prediction of HER2 Status Using ABVS Ultrasound Imaging, thesis, Lanzhou University.

Mira Y, 2023, The Value of Ultrasound Imaging and Nomogram Model in Distinguishing Benign and Malignant BI-RADS 4A Irregular Breast Masses, thesis, Xinjiang Medical University.

Li C, Chen C, 2023, Research Progress in Applying Ultrasound Imaging in Breast Tumors. Imaging Research and Medical Applications, 7(5): 5–7.

Li Q, 2022, Research on Building a Prediction Model for Benign and Malignant Breast Tumors Based on Ultrasound Imaging, thesis, Bengbu Medical College.

Shi S, 2022, The Value of Differentiating Benign and Malignant Breast Nodules Based on Ultrasound Imaging Logistic Regression Model, thesis, Jinzhou Medical University.

Qu N, 2021, Study on the Prediction of Benign and Malignant Breast Lesions and Axillary Lymph Node Status of Breast Cancer Using Dynamic Enhanced MRI and Radiomics, thesis, China Medical University.

Huang J, 2021, Research on the Value of Ultrasound Imaging in the Differential Diagnosis of Breast Phyllodes Tumors and Fibroadenomas, thesis, Guangxi Medical University.

Xiao R, 2021, The Value of Radiomics Based on Gray-Scale Ultrasound in Predicting Benign and Malignant Breast Tumors, thesis, Anhui Medical University.

Shi L, 2020, Diagnostic Value of Strain Elastography, Automated Breast Full-Volume Scanning Imaging, and Radiomics for Breast BI-RADS 4 Lesions, thesis, Suzhou University.

Jiang Q, Guo J, 2020, Research Progress of Ultrasound Imaging in Breast Cancer. Chinese Journal of Medical Ultrasound (Electronic Edition), 17(11): 1145–1148.